FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296894932> ?p ?o ?g. }

• W4296894932 endingPage "114777" @default.
• W4296894932 startingPage "114777" @default.
• W4296894932 abstract "A set of fifteen triterpenoid pyrazines and pyridines was prepared from parent triterpenoid 3-oxoderivatives (betulonic acid, dihydrobetulonic acid, oleanonic acid, moronic acid, ursonic acid, heterobetulonic acid, and allobetulone). Cytotoxicity of all compounds was tested in eight cancer and two non-cancer cell lines. Evaluation of the structure-activity relationships revealed that the triterpenoid core determined whether the final molecule is active or not, while the heterocycle is able to increase the activity and modulate the specificity. Five compounds (1b, 1c, 2b, 2c, and 8) were found to be preferentially and highly cytotoxic (IC50 ≈ 1 μM) against leukemic cancer cell lines (CCRF-CEM, K562, CEM-DNR, or K562-TAX). Surprisingly, compounds 1c, 2b, and 2c are 10-fold more active in multidrug-resistant leukemia cells (CEM-DNR and K562-TAX) than in their non-resistant analogs (CCRF-CEM and K562). Pharmacological parameters were measured for the most promising candidates and two types of prodrugs were synthesized: 1) Sugar-containing conjugates, most of which had improved cell penetration and retained high cytotoxicity in the CCRF-CEM cell line, unfortunately, they lost the selectivity against resistant cells. 2) Medoxomil derivatives, among which compounds 26-28 gained activities of IC50 0.026-0.043 μM against K562 cells. Compounds 1b, 8, 21, 22, 23, and 24 were selected for the evaluation of the mechanism of action based on their highest cytotoxicity against CCRF-CEM cell line. Several experiments showed that the majority of them cause apoptosis via the mitochondrial pathway. Compounds 1b, 8, and 21 inhibit growth and disintegrate spheroid cultures of HCT116 and HeLa cells, which would be important for the treatment of solid tumors. In summary, compounds 1b, 1c, 2b, 2c, 24, and 26-28 are highly and selectively cytotoxic against cancer cell lines and were selected for future in vivo tests and further development of anticancer drugs." @default.
• W4296894932 created "2022-09-24" @default.
• W4296894932 creator A5005249211 @default.
• W4296894932 creator A5006331005 @default.
• W4296894932 creator A5020353960 @default.
• W4296894932 creator A5022267622 @default.
• W4296894932 creator A5024903730 @default.
• W4296894932 creator A5025125941 @default.
• W4296894932 creator A5028402946 @default.
• W4296894932 creator A5029805801 @default.
• W4296894932 creator A5033639601 @default.
• W4296894932 creator A5035166463 @default.
• W4296894932 creator A5037983418 @default.
• W4296894932 creator A5040436840 @default.
• W4296894932 creator A5041943582 @default.
• W4296894932 creator A5045416342 @default.
• W4296894932 creator A5050451767 @default.
• W4296894932 creator A5052283665 @default.
• W4296894932 creator A5071146861 @default.
• W4296894932 creator A5084633296 @default.
• W4296894932 date "2022-12-01" @default.
• W4296894932 modified "2023-09-30" @default.
• W4296894932 title "Triterpenoid pyrazines and pyridines – Synthesis, cytotoxicity, mechanism of action, preparation of prodrugs" @default.
• W4296894932 cites W1151977996 @default.
• W4296894932 cites W1506642042 @default.
• W4296894932 cites W1774768800 @default.
• W4296894932 cites W1911342746 @default.
• W4296894932 cites W1966081420 @default.
• W4296894932 cites W1968872085 @default.
• W4296894932 cites W1970184435 @default.
• W4296894932 cites W1977711675 @default.
• W4296894932 cites W1984547206 @default.
• W4296894932 cites W1995861796 @default.
• W4296894932 cites W1996180957 @default.
• W4296894932 cites W2010298858 @default.
• W4296894932 cites W2011125717 @default.
• W4296894932 cites W2013480268 @default.
• W4296894932 cites W2014493202 @default.
• W4296894932 cites W2017074079 @default.
• W4296894932 cites W2024996523 @default.
• W4296894932 cites W2028526641 @default.
• W4296894932 cites W2029362726 @default.
• W4296894932 cites W2046827775 @default.
• W4296894932 cites W2057159876 @default.
• W4296894932 cites W2073101936 @default.
• W4296894932 cites W2084383881 @default.
• W4296894932 cites W2091138510 @default.
• W4296894932 cites W2093008432 @default.
• W4296894932 cites W2138511186 @default.
• W4296894932 cites W2139436435 @default.
• W4296894932 cites W2146983373 @default.
• W4296894932 cites W2158468919 @default.
• W4296894932 cites W2236665067 @default.
• W4296894932 cites W2258638464 @default.
• W4296894932 cites W2292014629 @default.
• W4296894932 cites W2331086861 @default.
• W4296894932 cites W2335617625 @default.
• W4296894932 cites W2403131015 @default.
• W4296894932 cites W2408054456 @default.
• W4296894932 cites W2463306689 @default.
• W4296894932 cites W2529449388 @default.
• W4296894932 cites W2576779654 @default.
• W4296894932 cites W2584933368 @default.
• W4296894932 cites W2758444615 @default.
• W4296894932 cites W2762324767 @default.
• W4296894932 cites W2901617531 @default.
• W4296894932 cites W2942134096 @default.
• W4296894932 cites W2975283146 @default.
• W4296894932 cites W2981477066 @default.
• W4296894932 cites W2990177956 @default.
• W4296894932 cites W3178326138 @default.
• W4296894932 cites W3184031446 @default.
• W4296894932 cites W3188902964 @default.
• W4296894932 cites W3207232060 @default.
• W4296894932 cites W3217616836 @default.
• W4296894932 doi "https://doi.org/10.1016/j.ejmech.2022.114777" @default.
• W4296894932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36174412" @default.
• W4296894932 hasPublicationYear "2022" @default.
• W4296894932 type Work @default.
• W4296894932 citedByCount "5" @default.
• W4296894932 countsByYear W42968949322022 @default.
• W4296894932 countsByYear W42968949322023 @default.
• W4296894932 crossrefType "journal-article" @default.
• W4296894932 hasAuthorship W4296894932A5005249211 @default.
• W4296894932 hasAuthorship W4296894932A5006331005 @default.
• W4296894932 hasAuthorship W4296894932A5020353960 @default.
• W4296894932 hasAuthorship W4296894932A5022267622 @default.
• W4296894932 hasAuthorship W4296894932A5024903730 @default.
• W4296894932 hasAuthorship W4296894932A5025125941 @default.
• W4296894932 hasAuthorship W4296894932A5028402946 @default.
• W4296894932 hasAuthorship W4296894932A5029805801 @default.
• W4296894932 hasAuthorship W4296894932A5033639601 @default.
• W4296894932 hasAuthorship W4296894932A5035166463 @default.
• W4296894932 hasAuthorship W4296894932A5037983418 @default.
• W4296894932 hasAuthorship W4296894932A5040436840 @default.
• W4296894932 hasAuthorship W4296894932A5041943582 @default.
• W4296894932 hasAuthorship W4296894932A5045416342 @default.
• W4296894932 hasAuthorship W4296894932A5050451767 @default.

• next